When estimating the effect of GLP-1R-based agonists on risk factors for MASLD, they showed similar estimates on HDL-C, TG, and ISI
O Orphenagesic, Orphenagesic Forte, Orudis, Oruvail Capsules, Oxycodine, Oxycodone P P-A-C, Pabalate-SF, Pabrin, Pacaps, Pain Reliever Tablets, Pamprin-IB, Panalgesic, Panodynes, Papaya, PediaProfen, Pedrazil, Pentasa, Pepto-Bismol, Percodan, Percodan Demi Tabs, Persantin, Persisin, Persistin, Pertofrane, PetoBismol, Phenaphen, Phenetron Compound, Phenylpropanilamine Pondimin (Fenfluramine), Piroxicam Capsules, Polymyxin, Ponstel Capsules, Prednisone, Presalin, Propanolol, Propulsid, Propoxyphene, Propoxyphene Compound, Propoxyphene Napsylate with Aspirin, Protamine, Prozac, Pyrroxate Q Quagesic, Quiet World Analgesic (sleeping aid), Quinine R Redux (Dexenfluramine), Relafen Tablets, Rexolate, Rhinex, Robaxin, Robasisal, Robaxisal, Roxiprin Tablets, Ru-Tuss, Rufin, S S-A-C, Sal-Sayne, Salabuff, Salatin
10.1021/jm801449a J
Nutrients 12 , 2525 (2020)
The early results are exciting: Retatrutide could offer a solution for people who haven't been able to reach a healthy weight with other GLP-1s
